Buy or sell Aktana stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Aktana Stock

Aktana delivers data-fueled insights and suggestions to life science sales reps, driving better decision-making and improved results.




San Francisco CA, US

Total Funding


About Aktana Stock

Aktana helps life science companies get the most out of artificial intelligence (AI) for commercializing their products. The company’s proprietary platform harnesses machine learning algorithms to enable marketing and sales teams to optimize their engagement with prescribing physicians. Aktana supports more than 100 brands and more than half the top 20 pharmaceutical companies worldwide to increase revenue, capitalize on data investments, and drive channel productivity and results. The company’s focus on the life sciences market allows Aktana to understand and incorporate unique market dynamics more deeply than the major AI players. Headquartered in San Francisco, Aktana also has offices in New York, Philadelphia, London, Barcelona, Tokyo, Osaka, and Shanghai.

Funding History

August 2011$3.0M
May 2012$2.0M
June 2013$5.5M
June 2016$17.6M
September 2018$21.0M


Head of Sales, Europe

Marshall Pillay

Chief Technology Officer and VP of Engineering

Jin Huang

Chief Financial Officer

Richard Van Hoesen

Chief Science Officer

Marc Cohen

Chief Marketing Officer

Clay Hausmann

VP and Head of Customer Success, Europe

Ywan Karlen

President and CEO

David Ehrlich

General Manager, Japan

Rob Willson

Vice President of Sales, North America

John Schultz


Eric Gilbert


Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Aktana or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: